GlaxoSmithKline says it is investigating bribery claims in Jordan and Lebanon
Allegations say GSK sales representatives bribed doctors by issuing free samples that they were then allowed to sell on
GlaxoSmithKline, the UK’s largest drug firm, is investigating claims that its staff in Jordan and Lebanon have bribed doctors. The inquiry comes after separate allegations of unscrupulous behaviour by staff in China, Iraq and Poland, with the last two of those cases both emerging earlier this month.
"GSK can confirm we are investigating allegations regarding the activity of a small number of individuals in our operations in Jordan and Lebanon," the company said in statement. "We started investigating using internal and external teams as soon as we became aware of these claims. These investigations have not yet concluded."
More From Around the Web
Check out these Articles
- A decent outcome as leveraged buyout brigade outbid for Ribena and Lucozade...
- Hall of Fame Member, Joyce L. Morrison, to be Honored with a Times Square, ...
- Statins guidance to GPs is a victory for vested interests over evidence | K...
- Global Drug Delivery Devices Market New Report by Data Bridge Market Resear...
- UK pharma firms accused of illegal deals to hike price of life-saving drug
- Aspirin could cut cancer risk, but may have side effects – video
- Do you buy medicine using online pharmacies? Share your experiences
- EU referendum makes gold miners and property oligarchs richer
- AstraZeneca shares up amid talk of possible takeover bid by Pfizer
- NuvOx Pharma Announces FDA Acceptance of IND to Initiate Clinical Trial for...
- GSK and Lundbeck Present on Improving Drug-Drug Interaction at ADMET 2016